CLINICAL_TRIALS
trial_result
· 2013-11-15
Clinical Trial Update: Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea [Phase 1]
Summary
A Phase 1 trial assessing safety and tolerability of AGN-199201 for erythema associated with rosacea has completed with posted results in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Rosacea, Erythema | Phase 1 | Status: COMPLETED | Results posted: 2013-11-15